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Real-time eye lens dose monitoring during cerebral angiography procedures
Abstract
Objectives: To develop a real-time dose-monitoring system to measure the patient’s eye lens dose during
neuro-interventional procedures. Methods: Radiation dose received at left outer canthus (LOC) and left
eyelid (LE) were measured using Metal-Oxide-Semiconductor Field-Effect Transistor dosimeters on 35 patients who underwent diagnostic or cerebral embolization procedures. Results: The radiation dose
received at the LOC region was significantly higher than the dose received by the LE. The maximum eye
lens dose of 1492 mGy was measured at LOC region for an AVM case, followed by 907 mGy for an
aneurysm case and 665 mGy for a diagnostic angiography procedure. Strong correlations (shown as R2)
were observed between kerma-area-product and measured eye doses (LOC:0.78, LE: 0.68). Lateral and
frontal air-kerma showed strong correlations with measured dose at LOC (AKL:0.93, AKF:0.78) and a
weak correlation with measured dose at LE. A moderate correlation was observed between fluoroscopic
time and dose measured at LE and LOC regions. Conclusions: The MO Skin dose-monitoring system
represents a new tool enabling real-time monitoring of eye lens dose during neuro-interventional
procedures. This system can provide interventionalists with information needed to adjust the clinical
procedure to control the patient’s dose. Key Points • Real-time patient dose monitoring helps
interventionalists to monitor doses. • Strong correlation was observed between kerma-area-product and
measured eye doses. • Radiation dose at left outer canthus was higher than at left eyelid
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Abstract Objectives: The purpose of this study was to develop a real-time
dose monitoring system to measure the patient’s eye lens dose during neurointerventional procedures. Methods: Radiation dose received at left outer
canthus (LOC) and left eyelid (LE) were measured using Metal-OxideSemiconductor Field-Effect Transistor dosimeters on 35 patients who
underwent diagnostic or cerebral embolization procedures. Results: The
radiation dose received at the LOC region was significantly higher than the
dose received by the LE. The maximum eye lens dose of 1492 mGy was
measured at LOC region for an AVM case, followed by 907 mGy for an
aneurysm case and 665 mGy for a diagnostic angiography procedure. Strong
correlations were observed between kerma-area-product and measured eye
doses (LOC: 0.78, LE: 0.68). Lateral and frontal air-kerma showed strong
correlations with measured dose at LOC (AKL: 0.93, AKF: 0.78) and weak
correlation with measured dose at LE. A moderate correlation was observed
between fluoroscopic time and dose measured at LE and LOC regions.
Conclusions: The MOSkin dose monitoring system represents a new tool
enabling real-time monitoring of patient’s eye lens dose during neurointerventional procedures. This system can provide interventionalists with
information needed to adjust the clinical procedure to control the patient’s
dose.
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Key point:
1.

Real-time patient dose monitoring helps interventionalists to monitor
patient’s dose.

2.

Strong correlation was observed between kerma-area-product and
measured patients’ eye doses

3.

Radiation dose at patients’ left outer canthus was higher than left eyelid

Abbreviation list:
1.

FT= Fluoroscopic time

2.

KAP= Kerma-area-product

3.

AK= Air kerma

4.

IRP= Interventional reference point

5.

LE= Left eyelid

6.

LOC= Left outer canthus

7.

MOSFET= Metal-Oxide-Semiconductor Field-Effect Transistor
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I.

Introduction

Fluoroscopy-guided interventional radiological procedures provide enormous
advantages over invasive surgical procedures. However, long radiation
exposure during complicated interventional radiology (IR) procedures remains
a concern. Skin injuries are the most frequently encountered tissue reaction
effects from IR procedures [1-4]. Different indirect dose evaluation techniques,
such as fluoroscopic time (FT), kerma-area-product (KAP), dose level at the
interventional reference point (IRP), and peak skin dose, have been established
as skin dose indicators for IR procedures [5, 6]. Other than skin dose, the
radiation dose to patient’s eye lens is also a concern, particularly for patients
undergoing long neuro-interventional procedures. Cataract formations are late
effects of radiation exposure. Unlike skin reactions, which are visible after
about 2 weeks, they usually appear after 10-20 years. To date, different
threshold doses have been proposed for cataract formation during acute
radiation exposure. The International Commission on Radiological Protection
(ICRP) [7], following recent epidemiology studies [8-11], issued a new
statement in 2011 on the threshold of 0.5 Gy in absorbed dose to eye lens.
Currently, different direct dosimeters have been used as post-processing dose
evaluation methods to evaluate the patient’s skin dose and eye lens dose during
IR procedures [12-17]. To the best of the authors’ knowledge, there is no real-
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time in vivo dosimetry system that has been used for patient dose monitoring
during IR procedures.
The purpose of the present study was to: first, demonstrate a new real-time
dose monitoring system for determining patient eye lens dose during neurointerventional procedures; and second, to evaluate correlations of the patient
eye lens dose with dose metric parameters, like KAP, FT, and AK of the
frontal (AKF) and lateral tube (AKL). In this study, our hypothesis was that not
all existing dose metric parameters are suitable to indicate patient’s eye lens
dose.

II.

Materials and Methods

II. A. Patients
The real-time monitoring of eye lens dose was carried out on 35 patients, 24
female patients (45 ±16.9 years) and 11 male patients (age 46 ±16.8 years),
comprising 19 diagnostic angiographies, 8 treatments of cerebral aneurysms,
and 8 embolizations of AVMs. The same interventionalist and radiography
team performed the neuro-interventional procedures from March 2013 to
March 2014.
II. B.

X-ray equipment

The neuro-interventional procedures were performed using an Allura Xper
5

FD20/20® biplane system (Philips Healthcare, Best, The Netherlands) at the
University of Malaya Medical Centre (UMMC). This suite consists of one
ceiling-mounted x-ray tube and one floor-mounted x-ray tube (C-arm)
equipped with a 30 cm x 38 cm dynamic flat detector. This machine is
equipped with different electronic rectangular field-of-views (FOVs), which
change the sensitive image detector area from 15 cm to 48 cm while the
exposure tube potential varies between 40 and 125 kVp. This machine can
generate five frame rate ranges for vascular procedures (0.5fps, 2fps, 3fps,
4fps, and 6fps) and two frame rate ranges for cardiac procedures (15fps and
30fps). The tube voltage is controlled by an automatic brightness control
system (ABC). The Allura Xper FD20/20 machine can apply different
filtrations, 0.2 mm, 0.5, and 1.0 mm copper equivalent, which are specified to
different types of exposures.
II. C. MOSkin Dosimetry system and measurement setup
MOSkin detector is a new type of Metal Oxide Semiconductor Field Effect
Transistor (MOSFET) detector designed by the Centre for Medical Radiation
Physics (CMRP), University of Wollongong, Australia. This detector was
specially designed for skin dose measurement and has previously been used for
patient skin dose measurement during radiotherapy procedures [18-22].
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This detector is composed of a hermitically sealed MOSFET detector in a
kapton strip using “drop-in” packaging technology [18]. A layer of polyamide
film protects and encapsulates the radiosensitive MOSFET sensor, as well as
provides a reproducible build-up layer with water equivalent depth of 0.07 mm
[Figure 1]. The principle of operation of the MOSkin detector is based on the
change of the threshold voltage (∆Vth), which is proportional to the irradiation
dose [19, ("Characterization of MOSkin detector for in vivo skin dose
measurement during interventional radiology procedures" by Safari MJ, Wong
JHD, Ng KH et al, submitted in September 2014, Medical Physics Journal)].
The MOSkin detector was characterized under Radiation Qualities in Radiation
beams emerging from the x-ray tube assembly (RQR) standard beam. This
detector proved to be reliable when exposed to different dose rates (±3%),
frame rates (±3%), radiation incident angles (±5%), and exposure energies
( ±5% ) ("Characterization of MOSkin detector for in vivo skin dose
measurement during interventional radiology procedures" by Safari MJ, Wong
JHD, Ng KH et al, submitted in September 2014, Medical Physics Journal).
The MOSkin detector response (∆Vth) can be recorded either manually from the
reader or automatically via computer software. In this study, a graphic user
interface, FETch, was designed to present the dose values in a more visual
form. This interface displays the accumulated dose in column bar charts and
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numeric form [Figure 2 (b)]. Dose measurements can be performed at userdefined readout frequencies (maximum temporal frequency is 1 Hz). With this
interface, the operators are able to monitor the radiation dose received by the
patient in a more intuitive and direct manner, providing valuable information
with minimal or no distraction to the interventionalist during a clinical
procedure.
II. B.

Data acquisition

For all the neuro-interventional procedures, the lateral x-ray tube was
positioned on the left side of the patients’ heads throughout the treatments. A
study of the exposure parameters during 53 neuro-interventional procedures
showed that, in 73.7% of the projection times, the frontal tube projections were
acquired in the posterior-anterior direction (10º RAO-10º LAO) and in 93% of
the time the lateral tube direction was changed from 70º RAO to 90º RAO.
("An investigation of the contribution of routine radiological exposure
parameters to patient’s dose during neuro-interventional radiology procedures:
A phantom study" by Safari MJ, Wong JHD, Jong WL et al, submitted in
March 2015, European Radiology). Therefore, the lenses of the left eyes were
constantly exposed to the primary x-ray beam from the lateral x-ray tube. The
difference between the radiation doses received in the left and right eyes during
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cerebral angiography procedures were studied in a pilot study on two patients,
which revealed that the radiation dose delivered to the left eye region is
significantly higher (~5 times) than the dose delivered to the right eye. For this
reason, in this study we focused on the measurement of the dose delivered to
patients’ left eye. The study of the patients’ eye lens dose was implemented
using MOSkin detectors. The patients were asked to keep their eyes closed
during the treatment procedure. Two MOSkin detectors were positioned on the
patient’s left outer canthus (LOC) and left eyelid (LE) [Figure 3(a)]. This
detector is not visible on the displayed image and does not interfere with the
treatment procedure [Figure 3(b)]. The MOSkin detectors were placed on the
patient’s body for at least 5 minutes to allow the detectors to equilibrate with
the patient’s body temperature before commencing the measurement. The
MOSkin dosimetry system equipped with acquisition laptop using FETch
software was placed in front of the interventionalist and the radiographer
during the treatment procedures [Figure 2(a)]. Exposure parameters were
recorded from the console. Measured doses were compared with exposure
parameters such as FT, KAP, AKF and AKL.
II. C.

Statistical analysis

Regression correlation tests were carried out to determine the relationships
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between the MOSkin response and total fluoroscopic time, KAP, AKL as well
as AKF. All analyses were carried out using SPSS (version 16, SPSS, Chicago,
IL).
III.

Results

II. A. Patient’s eye lens dose
The average dose received at the outer canthus and eyelid regions showed that
the radiation dose received at the outer canthus region was significantly higher
than the dose received at the eyelid region [Table 1]. The range of the AK for
each tube and, consequently, KAP for AVM procedures, was higher than for
other procedures. Due to higher dose delivery in AVM procedures, patients
received higher dose at the outer canthus and eyelid locations [Table 1 and
Figure 4].
Figure 5 shows the correlation between the exposure parameters and received
dose at LE and LOC. There is a strong correlation between accumulative KAP
and dose values at LE and LOC regions (LOC: R2=0.78 and LE: R2=0.68)
[Figure 5 (a)]. Moderate correlations were observed between total fluoroscopic
time and dose at LE and LOC (LOC: R2=0.52 and LE: R2=0.40) [Figure 5 (b)].
The accumulative AK for lateral and frontal tubes shows a strong correlation
with measured dose at LOC (AKL: 0.93 and AKF: 0.78) [Figure 5 (c, d)] but a
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weak correlation with measured dose at LE (AKL: 0.28 and AKF: 0.10) [Figure
5 (c, d)].

II. B. Study of exposure parameters
Figure 6 shows the accumulated dose trend at LOC for a particular AVM case,
highlighting the unique capability of the MOSkin dosimetry system. Using the
MOSkin detector, we can study the trend of the patient’s accumulated dose
during an interventional procedure. By matching the MOSkin detector response
and exposure time from the console, we can correlate the dose measured by the
MOSkin

detectors

with

the

machine

exposure

parameters,

thereby

understanding their contribution to the patient’s received dose. The system not
only enables us to record real-time patient dose, but also enables us to
investigate the contribution of each exposure to patient’s dose in terms of
exposure parameters (kV, mAs, exposure angulation and rotation and number
of frames) [Figure 6] or exposure types (Fluoroscopy, DSA, cine and road
mapping) [Figure 7]. From Figure 6, it was found that the sharp increments in
the detector threshold voltage were due to high dose rate DSA acquisition
technique. For this particular AVM procedure, the DSA contributed 94% of the
total dose to eye lens followed by road mapping (4.7%), cine trace (0.5%) and
fluoroscopy (0.8%). This information [Figure 6& Figure 7] is important in
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post-procedure analysis for future dose minimization strategies and can be
utilized for the interventionalists’ training.

IV.

Discussion

Different techniques have been recommended to reduce radiation dose during
IR procedures, such as using pulsed mode fluoroscopy exposure, shortening
the exposure time, increasing distance between x-ray source and patient,
reducing distance between image receptor and patient, minimizing the
magnification, maximizing collimation, using last image hold technique,
changing C-arm angles and using low frame rate exposure[23, 24].
Applying these strategies and using a direct dosimetry system can significantly
improve patient radiation safety during IR procedures. Direct dose
measurement is not feasible for all IR procedures; for this reason, the dose
metric parameters (FT, KAP, AKIRP) are regularly monitored and recorded. To
prevent skin injuries, a certain threshold level has been suggested for each
parameter, for instance FT 40-60 min, KAP 500 Gy.cm2, IRP 5 Gy and peak
skin dose 3 Gy [25]. While these parameters are mostly recorded after each IR
procedure as a rough estimate of the radiation dose received by patients, some
studies have shown that they do not provide sufficient information during a
procedure to control local skin dose to a given patient [5, 6, 26, 27]. The actual
12

patient’s entrance skin dose can be calculated from exposure air kerma at
reference point by incorporating table attenuation, backscatter factor,
correction of actual source skin distance (Inverse square law) of reference
point to actual skin point and correction of mass energy absorption coefficients
of skin to air [28]. Recently, automatic skin dose simulation tools were used to
estimate the entrance skin dose from the geometrical and exposure information
extracted from DICOM tags and system parameters. These software are able to
map the estimated skin dose distribution on standard and anatomical patient
model phantoms [28, 29].
In this study, KAP values showed strong correlation with doses received at LE
and LOC regions. For the cerebral angiography procedure, the patient’s eyes
are frequently exposed to primary radiation beams. This may be the main
reason that this strong correlation was observed between KAP and measured
dose at LE and LOC regions. In our center, the lateral tube was always placed
at the left side of the patient’s head, therefore AKL and measured doses at LE
and LOC showed strong correlation, unlike the frontal tube, which showed a
weak correlation with the measured doses.
For all cases measured dose at LOC was higher than LE. This difference can
be explained by two reasons: first, the closer proximity of the LOC detector to
the lateral x-ray tube compared to the LE detector; and second, collimation of
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the radiation field. The radiography team was well trained to minimize the
irradiation dose to the left eye lens by collimating the radiation field of the
lateral tube. With proper collimation of the radiation field, the detector on the
eyelid would be out of direct radiation from the lateral tube, while the detector
on the outer canthus would still be within the direct beam. The collimation
effect would be significant for embolization procedures at the posterior region
of the skull, which can completely place the patient’s eyes outside of the
primary beam. This finding clearly shows the importance of choosing the right
location for the point dose measurement during a non-homogenous dose
distribution procedure. The maximum eye lens dose of 1492 mGy was
measured at LOC region for an AVM case, followed by 907 mGy for an
aneurysm case and 665 mGy for a diagnostic angiography procedure.
This study showed that among the 35 patients, LOC regions of 8 patients and
LE region of 1 patient were found to receive higher doses than the assumed
threshold dose for cataract formation (500 mGy). Recent studies have reported
the average and maximum patient eye doses for neuro-interventional radiology
procedures [Table 2]. Generally, therapeutic procedures are more complicated
than diagnostic procedures, which lead to longer exposure time and higher
dose delivery to patients’ bodies (KAP). The results of our study are in good
agreement with previous studies. As shown, the detectors positioned at the
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lateral margin received higher doses in comparison to those placed on the
eyelids or inferior and superior margins (I-S margins).
As a high frame rate and high quality imaging technique, DSA plays a major
role in contributing to patient’s dose. Some studies have tried to evaluate the
effect of DSA exposure on patient dose [30, 31]. The MOSkin detector enables
us to study the contribution of various exposure parameters on patient’s dose
during a clinical procedure. However, the main objective of the patient
dosimetry is to monitor the total dose delivered to the patient’s body as well as
the dose delivered to the sensitive organs. A real-time dose monitoring system
can provide real-time information for each particular exposure. This
information can be used to study the techniques to optimize patient's radiation
safety during IR procedures, such as changing the exposure angulation,
adjusting the exposure collimation, and shortening the exposure time when the
dose at detector position reaches a critical level.
In summary, indirect dose measurements using machine available dose metrics
such as KAP, FT and air kerma are not accurate indicators of the actual dose
received by patients undergoing interventional radiological procedures. This
information can only be obtained via actual in-vivo dose measurements. In this
work, we demonstrated the feasibility of using the MOSkin dose monitoring
system as a real time, in-vivo dose measurement system. The system was
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successfully used to measure patient eye lens dose during neuro-interventional
procedures. This system enables interventionalists to have better awareness of
the patient’s eye lens dose during clinical procedures.
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List of figures:

Figure 1 (a) MOSkin dosimetry system (b) MOSkin detector and (c) MOSkin detector
components.
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Figure 2 (a) MOSkin dosimetry system was placed at treatment room and accumulated
dose values were displayed using the FETch software in front of the interventionalist and
the radiographer during treatment procedures. (b) FETch display showing the
accumulated dose values.

Figure 3 (a) The MOSkin detectors were positioned on the left eyelid and left outer
canthus regions during interventional procedures. (b) This detector is almost invisible on
the displayed image.
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Figure 4 The boxplot shows the median and distribution of the dose delivered to the
outer canthus and eyelid areas for each treatment procedure for the 35 participating
patients, comprising 19 diagnostic angiographies, 8 treatments of cerebral aneurysms,
and 8 embolizations of AVMs.
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Figure 5 Correlation between the measured dose to left outer canthus and left eyelid
regions to (a) KAP, (b) FT, (c) AKL and (d) AKF.
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Figure 6 The accumulated dose trend line at LOC for an AVM procedure. From the realtime response pattern of the MOSkin detector, it is possible to investigate the dose
delivered to the patients. The temporal dose pattern allows us to evaluate the contribution
of each exposure to dose delivery to the patient’s eye. Two particular exposures were
labeled in this graph, d1 is dose before exposure and d2 is the dose after exposure. The
increment dose (∆d) indicates the absorbed
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Figure 7 The dose delivered to the patient’s LOC depicted as contribution of different
types of exposure (e.g. fluoroscopy, road mapping, DSA and Cine Trace).
List of Tables:
Table 1 Exposure parameters and dose delivered to LE and LOC areas, averages,
medians, and 95th percentiles.
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Table 2 Comparison of published data on eye doses for neuro-interventional radiology
procedure.
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